A detailed history of Joel Isaacson & Co., LLC transactions in Compugen LTD stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 52,000 shares of CGEN stock, worth $79,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,000
Previous 22,000 136.36%
Holding current value
$79,040
Previous $36,000 161.11%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$1.56 - $2.1 $46,800 - $63,000
30,000 Added 136.36%
52,000 $94,000
Q4 2022

Jan 27, 2023

BUY
$0.58 - $1.2 $12,760 - $26,400
22,000 New
22,000 $0

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $132M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Joel Isaacson & Co., LLC Portfolio

Follow Joel Isaacson & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.